Sabra Health Care REIT (NASDAQ:SBRA) Releases FY 2025 Earnings Guidance

Sabra Health Care REIT (NASDAQ:SBRA) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.430-1.460 for the period, compared to the consensus estimate of 1.480. The company issued revenue guidance of -.

Sabra Health Care REIT Stock Performance

Sabra Health Care REIT stock traded down $0.50 during midday trading on Friday, reaching $15.89. 568,936 shares of the stock traded hands, compared to its average volume of 2,005,909. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. The firm has a fifty day moving average price of $16.88 and a two-hundred day moving average price of $17.62. The firm has a market cap of $3.76 billion, a price-to-earnings ratio of 30.04, a PEG ratio of 1.99 and a beta of 1.25. Sabra Health Care REIT has a fifty-two week low of $13.31 and a fifty-two week high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.36. The firm had revenue of $182.35 million during the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.59%. On average, equities research analysts forecast that Sabra Health Care REIT will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 7.55%. The ex-dividend date is Friday, February 14th. Sabra Health Care REIT’s payout ratio is 226.42%.

Analysts Set New Price Targets

A number of research analysts have issued reports on SBRA shares. Mizuho reissued a “neutral” rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a research report on Tuesday, January 7th. Citizens Jmp upgraded shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Finally, Truist Financial downgraded shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and dropped their price target for the stock from $18.00 to $17.00 in a research report on Friday, January 17th. Three analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.